Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Clinical Features and Treatment Strategies of Precursor B-cell Lymphoblastic Leukemia with C-myC Rearrangement in Childhood
  • +6
  • Xiang Wang,
  • Jun Huang,
  • kefei Wu,
  • Lisha Yu,
  • Ci Pan,
  • Jing Chen,
  • Shuhong Shen,
  • Changcheng Chen,
  • Qiang Mi
Xiang Wang
Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
Author Profile
Jun Huang
Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
Author Profile
kefei Wu
Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
Author Profile
Lisha Yu
Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
Author Profile
Ci Pan
Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
Author Profile
Jing Chen
Shanghai Childrens Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
Author Profile
Shuhong Shen
Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
Author Profile
Changcheng Chen
Shanghai Childrens Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
Author Profile
Qiang Mi
Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine

Corresponding Author:[email protected]

Author Profile

Abstract

Background: “Rare cases of Burkitt leukemia/lymphoma (BL) exhibiting a precursor B-cell phenotype (termed herein pre-BLL) were admitted by WHO Classification of Hematopoetic and Lymphoid Tissue, recent evidence suggests that these neoplasms genetically and epigenetically resemble precursor B-cell leukemia/lymphoma (pB-acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL)/LBL) rather than BL. The clinical features and treatment of childhood pre-BLL with C-myC rearrangement are poorly understood. Methods:The clinical features, treatment strategies and follow-up information of 9 cases with pre-BLL diagnosed by Shanghai Children’s Medical Center affiliated to Shanghai Jiao Tong University School of Medicine from 2011 to 2020 were retrospectively analyzed. Results: All the 9 cases were confirmed to be pre-BLL by flow cytometry and fluorescence in situ hybridization, morphological classification were L2/L3, immunophenotype was CD10, CD19 positive, CD20, TDT, CD34 selective expression, sIgM negative, Kappa and Lambda light chain negative. Most of the pre-BLL cases were accompanied by elevated lactate dehydrogenase (LDH), uric acid levels. 5 cases received intensive chemotherapy with overlapping regimen, and all achieved sustained remission except for 1 case relapse and death. Among the 4 cases who received low-intensity chemotherapy for acute lymphoblastic leukemia, 2 cases died due to early relapse of the disease. Conclusions: Pre-BLL cases are rare. and intensive chemotherapy treatment according to protocols for mature B-cell NHL. Currently, the treatment strategies are still controversial. Considering the small number of cases, multi-center clinical studies should be actively carried out to find a standard treatment plan.